{
    "Trade/Device Name(s)": [
        "RapidFRET Oral Fluid Assay for OPIATES",
        "RapidFRET Oral Fluid Calibrator Set",
        "RapidFRET Oral Fluid Control Set"
    ],
    "Submitter Information": "Biophor Diagnostics, Inc.",
    "510(k) Number": "K133642",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101754"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "January 24, 2014",
    "Summary Letter Received Date": "November 27, 2013",
    "Submission Date": "November 26, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Clinical toxicology calibrator",
        "Drug mixture control materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Opiates",
        "Morphine",
        "6-Monoacetylmorphine",
        "Amitriptyline",
        "Chlorpromazine",
        "Clomipramine",
        "Codeine",
        "Cyclizine",
        "Cyclobenzaprine",
        "Desipramine",
        "Diacetylmorphine (Heroin)",
        "Dihydrocodeine",
        "Doxepin",
        "d-Propoxyphene",
        "Ethylmorphine",
        "Flurazepam",
        "Hydrocodone",
        "Hydromorphone",
        "Imipramine",
        "Levorphanol",
        "Meperidine",
        "Morphine-3\u03b2DG",
        "Nalorphine",
        "Naloxone",
        "Naltrexone",
        "Normorphine",
        "Oxycodone",
        "Oxymorphone",
        "Rifampin",
        "Thioridazine",
        "Trimipramine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Glass sample tube with inert screw cap"
    ],
    "Instrument(s)/Platform(s)": [
        "RapidFRET Integrated Workstation"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive homogeneous immunoassay",
        "Time-resolved fluorescence",
        "Fluorescence resonance energy transfer (FRET)"
    ],
    "Methodologies": [
        "Competitive immunoassay",
        "FRET-based fluorescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for RapidFRET Oral Fluid Assay for OPIATES, including calibrator and control sets, using competitive FRET-based immunoassay for opiate detection in oral fluid.",
    "Indications for Use Summary": "Qualitative screening for opiates at 40 ng/mL in neat oral fluid samples collected with the RapidEASE Oral Fluid Collector on the RapidFRET Integrated Workstation for prescription use in central laboratories; provides preliminary results for In Vitro Diagnostic Use Only.",
    "fda_folder": "Toxicology"
}